Bloomage BioTech Chairman and Executive Director Ms. ZHAO Yan Wins EY Entrepreneur of The Year China 2016 Award

Monday, November 28, 2016 General News
Email Print This Page Comment bookmark
Font : A-A+

Seize the Opportunity and Lead Innovation

HONG KONG, Nov. 28, 2016 /PRNewswire/ -- Ms. ZHAO Yan, Chairman and

Executive Director of Bloomage BioTechnology Corporation Limited ("Bloomage BioTech" or "the Company"; together with its subsidiaries, collectively referred to as "the Group", stock code: 00963) has been granted the award of Pharmaceutical and Life Sciences
of EY Entrepreneur Of The Year 2016 China for her outstanding entrepreneurial achievements.

Created in the United States in 1986 and has grown to more than 145 cities in 60 countries and regions over the years, the EY Entrepreneur Of The Year awards program is one of the world's most prestigious business accolades for entrepreneurs as it honors entrepreneurs who inspire others with their outstanding vision, leadership and achievement. It is considered as the Oscars of the entrepreneurs world. In 2006, EY Entrepreneur Awards launched its China program, which has become a widely recognized and reputable award across the country.

Bloomage BioTechnology Corporation Limited is the world's largest manufacturer of raw material of sodium hyaluranate (also known as hyaluronic acid, Sub-Q; referred to as "HA") as well as the leading provider of medical cosmetic products and services in China. The award is a significant affirmation of Ms. ZHAO Yan's stable achievements in the industry as well as the Group's outstanding performance. Moreover, Ms. ZHAO Yan has been making great efforts in talent development with her humble and sincere leadership to make the Chinese HA industry leap forward to a new chapter.

Ms. ZHAO Yan, Chairman and Executive Director of Bloomage BioTech, said, "The award is more than a recognition for our past achievements. It is a new starting point of the future challenges, which not only belongs to me, but also to Bloomage BioTech and the entire industry." She also emphasized that, "The Group always takes technology innovation as its driving force. Over the past two decades, we have gone through the research from HA raw materials to end products, as well as the improvement to be an integrated medical beauty solutions provider. Our dream is to become the UBER of medical beauty industry, which every customer can benefit from. Looking ahead, the Group will continually focus on developing new technology and products to achieve a more diversified product structure. Meanwhile, we will constantly implement our innovation strategy to keep the advantageous position in the competition, striving to achieve long-term and continuous development for the Group."

About BloomageBioTechnology Corporation LimitedBloomageBioTechonology Corporation Limited (Stock Code:00963.HK) is the world's largest hyaluronic acid (referred to as "HA") raw material manufacturer, China's biggest HA fillers and HA medical skin care product manufacturer. And The Company is committed to developing into the provider of the full series of products and integrated medical aesthetics solutions provider. The company was listed on the HKEX in 2008.

Wonderful Sky Financial Group Holdings Ltd.Nicole Liu / Ovina ZhuTel: (852) 3970 2298 / (852) 3757 4705Email: / /

To view the original version on PR Newswire, visit:

SOURCE Bloomage BioTech


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store